Clinical trial Recruiting at 1 site Observational Ages 19 and up

Shape-sensing robotic bronchoscopy to diagnose peripheral lung nodules

Official title: Shape-sensing Robotic-assisted Bronchoscopy (ssRAB) for Diagnosis of Peripheral Pulmonary Nodules: A Prospective Cohort Study in Korea (the ULSAN-ION Study)

Run by Ulsan University Hospital · NCT07057648 · Data updated 2026-11-12

This tests a shape-sensing robotic bronchoscopy to see if it can get tissue samples from adults in Korea with peripheral lung nodules.

Quick facts

Study typeObservational
Ages19 Years and up
SexAll
Enrollment100 (estimated)
SponsorUlsan University Hospital
Academic / other
Locations1 site (Ulsan)
StatusRecruiting
StartedJuly 9, 2025
Main results expectedDecember 31, 2026
Study endsMay 31, 2027
Registry record updatedFebruary 13, 2026
Trial IDNCT07057648 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 19 or older with solid or part-solid peripheral pulmonary nodules who need histologic diagnosis and are fit for bronchoscopy under sedation or general anesthesia (ECOG 0–2) are ideal candidates.

Probably not a fit

Patients with pure ground-glass nodules, significant bleeding risk, severe cardiopulmonary dysfunction preventing deep sedation, pregnancy, or life expectancy under six months are unlikely to benefit from this procedure.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, single-center observational cohort in which shape-sensing robotic-assisted bronchoscopy (ssRAB) replaces conventional bronchoscopy for patients needing tissue diagnosis of peripheral pulmonary nodules. Planning uses thin-section chest CT to create a 3D navigation map, and the ssRAB system uses shape-sensing fiber optics to guide and stabilize the bronchoscopic catheter to the target. Procedures are performed under sedation or general anesthesia with tissue sampling and safety monitoring, and patients are followed for adverse events and diagnostic outcomes for six months. The main focus is on diagnostic yield and safety of ssRAB in a Korean clinical setting.

Why it matters

Potential benefit: If successful, ssRAB could increase the chance of getting a definitive tissue diagnosis from bronchoscopy and reduce the need for riskier procedures.

How similar studies have gone: International studies of the same ssRAB system have reported diagnostic yields around 87–90% with favorable safety profiles, suggesting promising results outside Korea.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 19 years or older
* Solid or part-solid peripheral pulmonary nodules confirmed on chest computed tomography (CT)
* Patients requiring histological diagnosis as determined by the treating physician
* Patients eligible for bronchoscopy procedure
* Ability to provide written informed consent
* Eastern Cooperative Oncology Group (ECOG) performance status 0-2 or equivalent functional status allowing procedure under sedation or general anesthesia

Exclusion Criteria:

* Pure ground glass opacity nodules
* Bleeding tendency defined as platelet count less than 50,000/μL or International Normalized Ratio (INR) greater than 1.5
* Severe cardiopulmonary dysfunction precluding deep sedation or general anesthesia
* Pregnant or breastfeeding women
* Life expectancy less than 6 months as assessed by the treating physician
* Inability or unwillingness to provide informed consent
* Absolute contraindication to bronchoscopy including:

  * Severe hypoxemia (oxygen saturation \<90% on room air)
  * Severe pulmonary hypertension
  * Recent myocardial infarction (within 6 weeks)
  * Unstable angina
  * Malignant arrhythmias
* Participation in another interventional clinical trial that may interfere with study procedures or outcomes

Where it's running

  • Ulsan University Hospital
    Ulsan, South Korea
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.